Correlation Between Aclaris Therapeutics and Burning Rock

Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and Burning Rock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and Burning Rock into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aclaris Therapeutics and Burning Rock Biotech, you can compare the effects of market volatilities on Aclaris Therapeutics and Burning Rock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of Burning Rock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and Burning Rock.

Diversification Opportunities for Aclaris Therapeutics and Burning Rock

0.77

Correlation Coefficient

Aclaris Therapeutics  Burning Rock

Poor diversification

The 3 months correlation between Aclaris and Burning is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and Burning Rock Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Burning Rock Biotech and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with Burning Rock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Burning Rock Biotech has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and Burning Rock go up and down completely randomly.

Pair Corralation between Aclaris Therapeutics and Burning Rock

Given the investment horizon of 90 days Aclaris Therapeutics is expected to under-perform the Burning Rock. But the stock apears to be less risky and, when comparing its historical volatility, Aclaris Therapeutics is 1.75 times less risky than Burning Rock. The stock trades about -0.21 of its potential returns per unit of risk. The Burning Rock Biotech is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest  695.00  in Burning Rock Biotech on December 28, 2024 and sell it today you would lose (225.00) from holding Burning Rock Biotech or give up 32.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Aclaris Therapeutics  vs.  Burning Rock Biotech

Aclaris Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aclaris Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Burning Rock Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Burning Rock Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Aclaris Therapeutics and Burning Rock

The main advantage of trading using opposite Aclaris Therapeutics and Burning Rock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, Burning Rock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burning Rock will offset losses from the drop in Burning Rock's long position.

The idea behind Aclaris Therapeutics and Burning Rock Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.